Who are Pharming Group N.V.'s main suppliers?

Pharming Group N.V. (PHAR) key suppliers include: BIOCONNECTION-INVESTMENTS-B-V, SANOFI-S-A, Sanofi, Sanofi. View the full supplier network at chainsifter.com/chain/PHAR.

Who are Pharming Group N.V.'s major customers?

Pharming Group N.V. (PHAR) key customers include: SPECIALTY-PHARMACIES, ALMAC-GROUP, Sanofi, Sanofi. View the full customer network at chainsifter.com/chain/PHAR.

What sector is Pharming Group N.V. in?

Pharming Group N.V. (PHAR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

PHAR Supply Chain: Pharming Group N.V. Supplier List & 9 Relationships

4Suppliers

4Customers

1Debt Items

20Related Chains

Pharming Group N.V. Suppliers

Ticker	Name	Confidence	Evidence
BIOCONNECTION-INVESTMENTS-B-V	BIOCONNECTION-INVESTMENTS-B-V	90%	We have entered into (downstream) manufacturing and supply agreements for Joenja® and RUCONEST® with, among others, Sanofi S.A., or Sanofi, and BioConnection Investments B.V. (formerly BioConnection …
SANOFI-S-A	SANOFI-S-A	90%	We have entered into (downstream) manufacturing and supply agreements for Joenja® and RUCONEST® with, among others, Sanofi S.A., or Sanofi, and BioConnection Investments B.V.
SNYNF	Sanofi	72%	roducts could be impacted. We depend on third-party manufacturers for the production of Joenja® and for the production of rhC1INH for commercial supply and for use in clinical trials of RUCONEST®, as…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from PHAR graph: roducts could be impacted. We depend on third-party manufacturers for the production of Joenja® and for the producti…

Pharming Group N.V. Customers

Ticker	Name	Confidence	Evidence
SPECIALTY-PHARMACIES	SPECIALTY-PHARMACIES	90%	Two U.S. customers (namely specialty pharmacies) accounted for $290.9 million, or 77%, of our revenues for the year ended December 31, 2025, and $227.7 million, or 77%, of our revenues for the year e…
ALMAC-GROUP	ALMAC-GROUP	85%	ly remained uninterrupted across all commercial markets. C) Joenja® manufacturing Pursuant to our agreement with Novartis relating to Joenja®, we have agreed to manufacture both the drug substance as…
SNYNF	Sanofi	72%	roducts could be impacted. We depend on third-party manufacturers for the production of Joenja® and for the production of rhC1INH for commercial supply and for use in clinical trials of RUCONEST®, as…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from PHAR graph: roducts could be impacted. We depend on third-party manufacturers for the production of Joenja® and for the producti…

Pharming Group N.V. Debt Obligations

Instrument	Description	Confidence	Evidence
PHAR-DEBT	Debt stack $116.2M	90%	Market cache reports total debt of $116.2M.

Pharming Group N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Pharming Group N.V..

Pharming Group N.V. Ownership

Holder	Name	Confidence	Evidence
PHAR-OWNER-SILVERBERG-BERNSTEIN-CAPITAL-MAN	Silverberg Bernstein Capital Management LLC	90%	13F overlay lists Silverberg Bernstein Capital Management LLC as top holder; 12 tracked holders.

Pharming Group N.V. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
DSGN	Design Therapeutics, Inc.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
CBIO	Crescent Biopharma, Inc.	100.00	2
CCEP	Coca-Cola Europacific Partners PLC	100.00	2
WHWK	Whitehawk Therapeutics, Inc.	100.00	2
AZN	AstraZeneca PLC	100.00	2
FJET	Starfighters Space, Inc.	100.00	2
ANL	Adlai Nortye Ltd.	100.00	2
CVU	CPI Aerostructures, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
BNBX	BNB Plus Corp.	100.00	2
CTMX	CytomX Therapeutics, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
ALXO	ALX Oncology Holdings Inc.	100.00	2
BLRX	BioLineRx Ltd.	100.00	2
IMMP	Immutep Limited	100.00	2
BIOA	BioAge Labs, Inc.	100.00	2
CYTK	Cytokinetics, Incorporated	100.00	2
RYAOF	Ryanair Holdings plc	100.00	2

Pharming Group N.V. Supply Chain